Effect of Preemptive Ibuprofen and Dexketoprofen in Patients Undergoing Laparoscopic Cholecystectomy
1 other identifier
observational
90
1 country
1
Brief Summary
The primary aim of this study is to investigate the effects of preventive ibuprofen and dexketoprofen on postoperative opioid requirement in patients undergoing elective laparoscopic cholecystectomy. The secondary aim is to compare routine administration of preemptive ibuprofen and dexketoprofen in terms of intraoperative hemodynamic parameters, postoperative complications, and patient satisfaction
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 19, 2018
CompletedFirst Posted
Study publicly available on registry
July 31, 2018
CompletedStudy Start
First participant enrolled
August 20, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2023
CompletedMarch 26, 2024
March 1, 2024
4.1 years
July 19, 2018
March 24, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
opioid consumption
Total opioid consumption as microgram/kg will be assessed in 24 hour surgery
First 24 hours total opioid consumption
Study Arms (3)
Group I (Ibuprofen)
Ibuprofen Group will receive 800 mg iv ibuprofen in 100 cc of isotonic solution within 30 min before the procedure
Group D (Dexketoprofen
Dexketoprofen Group will receive 50 mg iv dexketoprofen in addition to 100 cc of isotonic solution within 30 min before the procedure
Placebo Group
will receive 100 cc of isotonic solution within 30 min before the procedure
Eligibility Criteria
patients undergoing laparoscopic cholecystectomy
You may qualify if:
- Patients scheduled for elective laparoscopic cholecystectomy.
- Aged 18-65 years
- ASA score of I and II.
You may not qualify if:
- Aged under 18 year Over 65 years Failure to provide a written consent Several cardiac failure, cronic renal failure, Pregnancy, A prior known allergic reaction to the drugs to be administered, Being unable to use patient-controlled analgesia (PCA) pumps, and conversion to open surgery during laparoscopy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Celaleddin Soyalp
Van, 65080, Turkey (Türkiye)
Related Publications (1)
Lee IO, Kim SH, Kong MH, Lee MK, Kim NS, Choi YS, Lim SH. Pain after laparoscopic cholecystectomy: the effect and timing of incisional and intraperitoneal bupivacaine. Can J Anaesth. 2001 Jun;48(6):545-50. doi: 10.1007/BF03016830.
PMID: 11444448BACKGROUND
Study Officials
- STUDY CHAIR
CELALEDDİN SOYALP
Yuzuncu Yil University Dursun Odabas Medical School Anesthesiology a nd Reanimation Department, Van, Turkey
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assist. prof.
Study Record Dates
First Submitted
July 19, 2018
First Posted
July 31, 2018
Study Start
August 20, 2018
Primary Completion
September 30, 2022
Study Completion
December 30, 2023
Last Updated
March 26, 2024
Record last verified: 2024-03